UBS Maintains Neutral on Xylem, Raises Price Target to $138
Benzinga Newsdesk 2 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst Joshua Spector maintains Xylem (NYSE:XYL) with a Neutral and raises the price target from $135 to $138.
UBS analyst Joshua Spector maintains Xylem (NYSE:XYL) with a Neutral and raises the price target from $135 to $138.